RA Capital Management »

Glaukos shares owned by RA Capital Management

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.4M 54k 81.55
2025-03-31 $19M 190k 98.42

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Glaukos

BlackRock
Vanguard Group
Wellington Management Company
PRIMECAP Management Company
State Street Corporation
Ameriprise Financial
Alliancebernstein
Geode Capital Management
Westfield Capital Management Company
William Blair Investment Management
Henderson Group
Millennium Management
Capital World Investors
Braidwell
Brown Capital Management

View all funds holding Glaukos